Results 141 to 150 of about 5,707,923 (204)

A systematic review of the efficacy of cancer vaccines in advanced breast cancer. [PDF]

Breast Cancer
Charalampopoulou A, Filippatos C, Malandrakis P, Zagouri F, Gavriatopoulou M, Ntanasis-Stathopoulos I.   +5 more
europepmc   +1 more source

A Comprehensive Review of Nanoadjuvants in Cancer Vaccines and Their Immunomodulatory Role and Clinical Applications. [PDF]

Arch Razi Inst
Mahan H, Neda M, Elahe DN, Nilufar HS, Mahsa F, Farjad Z, Amirhossein DD, Shiva D.   +7 more
europepmc   +1 more source

Engineering pyroptotic vesicles as personalized cancer vaccines. [PDF]

Nat Nanotechnol
Li Z, Wang Y, Mo F, Wolter T, Hong R, Barrett A, Richmond N, Liu F, Chen Y, Yang X, Dempsey L, Hu Q.   +11 more
europepmc   +1 more source

Strategic Advances in Targeted Delivery Carriers for Therapeutic Cancer Vaccines. [PDF]

Int J Mol Sci
Wu J, Liang J, Zhang Y, Dong C, Tan D, Wang H, Zheng Y, He Q.   +7 more
europepmc   +1 more source

Personalized Cancer Vaccines in Combination Therapies: Current Status and Future Prospects. [PDF]

Asian Pac J Cancer Prev
Rukhayya F, Katta L, Ghori HK, Kattela S, Parvez M, Posani S, Parmar MP, Jatin F, Sahu S, Younas S.   +9 more
europepmc   +1 more source

Therapeutic Colorectal Cancer Vaccines: Emerging Modalities and Translational Opportunities. [PDF]

Vaccines (Basel)
Muthukutty P, Woo HY, Yoo SY.
europepmc   +1 more source

Next-generation cancer vaccines: targeting cryptic and non-canonical antigens for precision immunotherapy. [PDF]

Explor Target Antitumor Ther
Anilkumar AS, Thomas SM, Veerabathiran R.   +2 more
europepmc   +1 more source

Harnessing immunotherapy: cancer vaccines as novel therapeutic strategies for brain tumor. [PDF]

Front Immunol
Kiel K, Piranlioglu R, Godlewski J, Bronisz A.   +3 more
europepmc   +1 more source

Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines

Zitvogel L, Carrier A, Manghi P, Silva CAC, Lahmar I, Birebent R, Suissa D, Laheurte C, Schreibelt G, Lemant L, FAHRNER J, de Sousa E, Berthier F, Villemonteix J, Chevalier M, Piccinno G, Hocquet D, Lebhar I, Maeurer M, Caillat-Zucman S, Kroemer G, Derosa L, Launay O, Golden E, Bol K, De Vries IJM, Adotévi O, Segata N, Formenti S, Kobold S, Pieper D, Vital M, Santos-Peral A, Zaucha M, García-Bengoa M, Thorn-Seshold J, Stirling H, Rothenfusser S, Iebba V, Almonte A, Ajami N, White M, Sahasrabhojane P, Hoballah Y, Losh J, DePinho C, Dondossola E, Wargo J.   +47 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Challenges in developing personalized neoantigen cancer vaccines

Nature Reviews Immunology, 2023
The recent success of cancer immunotherapies has highlighted the benefit of harnessing the immune system for cancer treatment. Vaccines have a long history of promoting immunity to pathogens and, consequently, vaccines targeting cancer neoantigens have ...
Peter Katsikis, Christopher Schliehe, Ken J Ishii   +2 more
exaly   +2 more sources